The 3D Printed Drugs Market was valued at US$ 37 Billion in 2025 and is projected to reach US$ 84.14 Billion by 2033, registering a CAGR of 10.82% during 2026–2033. The outlook is supported by personalized medicine and patient-specific dosing, decentralized and on-demand pharmaceutical manufacturing, and AI-supported dosage design and digital production workflows. However, high capital...